Pay in 4 interest-free payments of $5.19 Learn more
Ships within 48 hours Β· Estimated delivery Aug 7 - Aug 12
No participants withdrew from any trial due to tolerability issues, indicating that even when side effects occurred, they were sufficiently manageable that participants chose to continue treatment
Participants who were given a higher dose of AOD-9604 (10 mg/day) did not lose more weight
Fibroblast cultures were divided into control conditions and peptide-exposed conditions
Research Applications
Also, its important to note that itd be unsafe for certain groups of people to use either TB4 or TB-500, including those who are pregnant or breastfeeding and those who have suspected or active cancer
Injectable Dose: 0.1 to 0.2 mg three times weekly Topical Option: Apply serum to target areas twice daily Combined Approach: Injectable 3x weekly plus topical to specific areas Duration: 8 to 12 weeks, can extend longer due to favorable safety profile The timing of GHK-Cu introduction matters for maximum benefit
US$ 26.29
US$ 24.92
US$ 20.35
US$ 24.91
US$ 22.53
US$ 24.83
